Insulin aspart, recombinant Subcutaneous and Vecuronium Bromide
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Vecuronium Bromide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: vecuronium
Brand name: Vecuronium Bromide, Norcuron
Synonyms: Vecuronium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Vedolizumab
- Insulin aspart, recombinant Subcutaneous-Vedolizumab Intravenous
- Insulin aspart, recombinant Subcutaneous-Veetids
- Insulin aspart, recombinant Subcutaneous-Veetids (Penicillin V Potassium Oral Solution)
- Insulin aspart, recombinant Subcutaneous-Veetids (Penicillin V Potassium Tablets)
- Insulin aspart, recombinant Subcutaneous-Velban
- Vecuronium Bromide-Insulin degludec
- Vecuronium Bromide-Insulin Degludec (U-100) Prefilled Pens
- Vecuronium Bromide-Insulin Degludec (U-100) Vials
- Vecuronium Bromide-Insulin Degludec (U-200) Prefilled Pens
- Vecuronium Bromide-Insulin degludec and liraglutide
- Vecuronium Bromide-Insulin degludec and liraglutide Subcutaneous